Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 2 75 5 SULFITE FREE IN DEXTROSE 5 IN PLASTIC CONTAINER versus NOVAMINE 8 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 2 75 5 SULFITE FREE IN DEXTROSE 5 IN PLASTIC CONTAINER versus NOVAMINE 8 5.
CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER vs NOVAMINE 8.5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% provides exogenous amino acids and carbohydrates for parenteral nutrition. Amino acids are used for protein synthesis and nitrogen balance; dextrose provides caloric energy. The specific amino acid profile supports anabolism and tissue repair.
Novamine 8.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in patients who cannot obtain adequate nutrition enterally.
Intravenous infusion; typical adult dose is 500-1000 mL (providing 2.75% amino acids and 5% dextrose) infused at a rate not exceeding 100 mL/hour initially, adjusted based on metabolic and fluid requirements; continuous or intermittent infusion.
500 mL to 2000 mL intravenously per 24 hours, typically infused at a rate of 20 to 40 mL/hour; adjust based on metabolic and clinical response.
None Documented
None Documented
Not applicable as a fixed combination; dextrose has a plasma half-life of ~2 hours, amino acids are metabolized continuously.
Variable; amino acids have short t1/2 of minutes to hours. Clinical context: continuous infusion maintains steady state; elimination depends on metabolic demand and organ function.
Renal: amino acids and dextrose metabolites; hepatic: CO2 production. Urea nitrogen excretion accounts for ~80% of nitrogen elimination.
Renal: >95% as amino acids and metabolites. Biliary/fecal: <5%.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition